Mean PCL [ATP] (a) and mean serosal bath [ATP] (b) obtained from CF cultures 1 h after 50 μl of PBS addition under variable phasic motion (both, n = 4). NL PCL [ATP] was not significantly different from CF PCL ATP (1.9 ± 0.6, 12 ± 4, 95 ± 13, and 131 ± 41 nM at 0, 0.006, 0.6, and 6 dynes/cm2, respectively; all n = 4 and p < 0.05). c, mean PCL height after 48 h of phasic motion in the presence of mucosal apyrase (apyr., 5 units/ml) and/or 8-SPT (10 μM) in NL (open bars; n = 6 – 8) and CF (closed bars; n = 5–7). d, bumetanide (bumet.) and amiloride (amil.)-sensitive changes in Vt in NL (open bars, n = 8) and CF (closed bars, n = 4) cultures before (0) and 48 h after PBS addition/phasic motion in the presence of 5 units/ml mucosal apyrase. Note that amiloride and bumetanide values for CF cultures at 48 h are significantly different from the values without apyrase at 48 h (Fig. 3d). e, simultaneous measurements of Vt and intracellular calcium (Ca2+i) in CF cultures perfused bilaterally with Ringer solution. Left, changes in Vt/Ca2+i induced by stopping then restarting mucosal perfusion (denoted by arrows). Right, altered perfusion rates in the presence of mucosal apyrase (5 units/ml). The mean changes in Vt and Ca2+i responses to phasic perfusion with KBR were −7.8 ± 0.3 mV and 198 ± 12 nM, respectively (p < 0.05; n = 7); the changes in each parameter were significantly reduced in the presence of apyrase; ΔVt = −0.2 ± 0.1 mV, ΔCa2+ = 3 ± 2 nM, respectively (p < 0.05; n = 6). Data shown as the mean ± S.E. *, data significantly different between NL and CF cultures. †, data significantly different from t = 0. ‡, data significantly different from apyrase. §, data significantly different from 8-SPT.